About Us
Our Mission & Values
We know the problems that patients face with injection medications. We’ve seen it firsthand with our families and our patients.
Revolutionizing this process to give patients control over their medications is our mission. Patients deserve a better experience.
We Believe
Patients should be in control of their health
Patients should have more confidence in their care regimens
Patients deserve a less painful & anxiety-ridden approach to injections
Our Story
Frequently self-injecting medications for chronic conditions is difficult. But these injection medications are life-saving. Despite this, injection medication adherence can be as low as 50%. Sometimes it is easy to skip a dose, whether on purpose or on accident. However, individuals in these situations can be hospitalized and can die from injectable medication non-adherence.
After experiencing one too many close calls with our family and patients, our team decided to figure out why this was happening. We set out and surveyed hundreds of patients, interviewing dozens more about their experience with injectable medications. We found several common themes. Time and time again we received comments that current injection products can be so painful and harrowing that patients would often stop taking their life-prolonging medications altogether.
We quickly realized that without solving these core problems with the injection experience, patients would continue to not adhere to these life-changing therapies. This prompted Love Lifesciences to begin developing UniPen and MultiPen. We are revolutionizing the patient injection experience and looking to increase medication adherence and ultimately improve patient health outcomes.
We look to ensure all patients are given the opportunity to Love Life.
Our Team
Co-Founder & CEO
Nick received his MD and MBA degrees from the University of Kansas School of Medicine and School of Business. He has a background as a business analyst for multiple biopharma companies and has a research background in Medicinal Chemistry and Pediatric Neurodevelopment.
Co-Founder & CTO
Bradley has nearly a decade of experience founding and growing companies throughout various industries. He enjoys pairing his design and engineering background with technology and machinery to take novel ideas and develop them into products that will have positive impacts on people’s lives.
Meet OurAdvisors
Partner and CFO at Fulcrum Global Capital
Chief Technology Officer at DirectSync Surgical
President of Ascension Technologies
President at Kanpecia Biotech
Allergy Program Director at University of Kansas Health System
Executive Institutional Specialist at Janssen Pharmaceuticals
We Look To Ensure All Patients Are Given The Opportunity To Love Life
We are always interested in hearing from those that have an interest in our products or company.
We know that following our journey is one of the best ways to get you interested.
